Stopping Ozempic Raises Cardiovascular Risk by 22 Percent
A VA study of 600,000 patients found that quitting GLP-1 drugs for two years erased all cardiovascular benefits and then some.
Life
The Wegovy Pill Has 400,000 Americans and Weight Loss Will Never Be the Same
Four hundred thousand Americans started taking the oral Wegovy in ten weeks, and a third of them had never used a GLP-1 drug before.
GLP-1 Drugs May Also Reduce Substance Use Disorders
A VA study of 600,000 veterans found GLP-1 users were 15 to 20 percent less likely to be diagnosed with substance use disorders.
The Catholic Convert Surge Built on X Continued into Sunday Services
Record RCIA numbers across U.S. dioceses — 8,598 in Los Angeles alone — confirm that what X's Catholic influencers have been tracking all Lent is real.
Ozempic Is Changing What America Eats and Restaurants Are Adjusting
GLP-1 users consume 21 percent fewer calories and spend a third less on groceries — and Olive Garden just redesigned its menu around them.
The LaGuardia Investigation Has No New NTSB Directive
One week after the LaGuardia runway collision killed two pilots, the NTSB investigation continues without new directives or preliminary findings.
Global Heating May Drive Half a Million Extra Premature Deaths by 2050
A Lancet study projects that rising temperatures will make people too hot to exercise, contributing to 520,000 additional premature deaths annually by 2050.
GLP-1 Drugs Are a Social Transformation Not Just a Medical One
One in seven American adults now takes or has taken a GLP-1 drug — and the behavioral, social, and identity shifts are outrunning the clinical data.